Jupiter Life Line Hospitals Ltd
Jupiter Life Line Hospitals Ltd (JLHL) last traded at ₹298, a market capitalisation of ₹9,771 crore, on a P/E of 51.1. Over the past 52 weeks the stock has ranged between ₹230 and ₹340. Jupiter Life Line Hospitals Ltd last reported results for the quarter ended Jun 2026, with sales of ₹411 crore and net profit of ₹38 crore. Figures are as of 25 Aug 2026 and are not real time.
Jupiter Life Line Hospitals Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Jupiter Life Line Hospitals Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹411 cr, up 16.4% from ₹353 cr a year earlier. Net profit was ₹38 cr, down 13.6% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 335 | 333 | 337 | 353 | 394 | 365 | 388 | 411 |
| Expenses | 257 | 256 | 257 | 275 | 301 | 282 | 299 | 332 |
| Operating profit | 78 | 76 | 80 | 78 | 92 | 83 | 89 | 79 |
| OPM % | 23% | 23% | 24% | 22% | 23% | 23% | 23% | 19% |
| Other income | 7 | 7 | 7 | 13 | 11 | 3 | 11 | 11 |
| Interest | 1 | 3 | 6 | 8 | 8 | 8 | 9 | 13 |
| Depreciation | 14 | 14 | 18 | 21 | 21 | 22 | 23 | 26 |
| Profit before tax | 70 | 67 | 63 | 62 | 74 | 57 | 68 | 51 |
| Tax % | 26% | 22% | 28% | 29% | 23% | 25% | 26% | 26% |
| Net profit | 52 | 52 | 45 | 44 | 57 | 42 | 50 | 38 |
| EPS (₹) | 1.58 | 1.59 | 1.38 | 1.34 | 1.75 | 1.30 | 1.53 | 1.14 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Jupiter Life Line Hospitals Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 486 | 733 | 893 | 1,073 | 1,302 | 1,500 | 1,558 |
| Operating profit | 67 | 153 | 201 | 242 | 303 | 343 | 344 |
| OPM % | 14% | 21% | 23% | 23% | 23% | 23% | 22% |
| Net profit | -2 | 51 | 73 | 177 | 194 | 194 | 188 |
| EPS (₹) | -0.09 | 2.01 | 2.58 | 5.39 | 5.89 | 5.92 | 5.72 |
TTM is the trailing twelve months to the most recent quarter.
Jupiter Life Line Hospitals Ltd growth and returns
- 10 Years
- %
- 5 Years
- 25%
- 3 Years
- 19%
- TTM
- 15%
- 10 Years
- %
- 5 Years
- 143%
- 3 Years
- 37%
- TTM
- -1%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- 9%
- 10 Years
- %
- 5 Years
- 17%
- 3 Years
- 16%
- Last Year
- 13%
Jupiter Life Line Hospitals Ltd shareholding pattern
Promoters held 40.91% at Jun 2026, broadly unchanged since Jun 2025. FIIs 9.37% and DIIs 16.51%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% |
| FIIs | 8.84% | 10.04% | 10.04% | 9.77% | 9.06% | 8.48% | 8.48% | 9.37% |
| DIIs | 13.46% | 15.75% | 15.64% | 15.82% | 16.97% | 17.44% | 17.01% | 16.51% |
| Public | 36.79% | 33.31% | 33.43% | 33.51% | 33.08% | 33.17% | 33.60% | 33.20% |
| No. of shareholders | 34,081 | 33,914 | 33,956 | 34,192 | 34,361 | 33,620 | 32,985 | 33,194 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Jupiter Life Line Hospitals Ltd corporate filings
- Q1 FY27 Earnings Conference Call - TranscriptCompany Updatemedium impact
Cruxal's analysis: Jupiter Life Line Hospitals reported Q1 FY27 total income of INR411 crore with an EBITDA…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Jupiter Life Line Hospitals Ltd
Cruxal reads every Jupiter Life Line Hospitals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.